The agency cited quality issues at facilities testing Dexcom’s G6 and G7 monitors, including inadequate validation and risk ...

Nanowear announced that it entered into a partnership with Dexcom to ingest glucose data from its latest continuous glucose ...

Nanowear, a leader in home-based cardiometabolic digital diagnostics announced that SimpleSense™, a nanotechnology-enabled wearable, mobile and software diagnostics platform, will ingest glucose data ...

Jake Leach caught up with MedTech Dive during the ATTD conference to discuss new data on the company’s glucose monitors.

Last week marked the FDA's deadline for compounders to stop making the obesity drug tirzepatide (Zepbound), leaving some ...